150 related articles for article (PubMed ID: 7116758)
21. Acute management of severe hypertension with oral labetalol.
Ghose RR
Br J Clin Pharmacol; 1979; 8(Suppl 2):189S-193S. PubMed ID: 526400
[TBL] [Abstract][Full Text] [Related]
22. Dose-response evaluation of oral labetalol in patients presenting to the emergency department with accelerated hypertension.
Gonzalez ER; Peterson MA; Racht EM; Ornato JP; Due DL
Ann Emerg Med; 1991 Apr; 20(4):333-8. PubMed ID: 2003657
[TBL] [Abstract][Full Text] [Related]
23. The effect of exercise on intra-arterial blood pressure and pulse rate before and during long-term high-dose treatment with labetalol in patients with severe, therapy-resistant hypertension.
la Cour Petersen E; Kristensen BO
Postgrad Med J; 1980; 56 Suppl 2():60-4. PubMed ID: 7433345
[TBL] [Abstract][Full Text] [Related]
24. Intravenous dilevalol. Effects of the R-R optical isomer of labetalol in patients with severe hypertension.
Wallin JD; Cook ME; Clifton GG; Blasucci DJ; Poland M
Arch Intern Med; 1988 Mar; 148(3):534-8. PubMed ID: 3277568
[TBL] [Abstract][Full Text] [Related]
25. Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol.
Trust PM; Rosei EA; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):799-803. PubMed ID: 791333
[TBL] [Abstract][Full Text] [Related]
26. Labetalol infusion in acute myocardial infarction with systemic hypertension.
Marx PG; Reid DS
Br J Clin Pharmacol; 1979; 8(Suppl 2):233S-238S. PubMed ID: 526407
[TBL] [Abstract][Full Text] [Related]
27. Treatment of severe essential hypertension with labetalol: effect on active and inactive renin.
Hauger-Klevene JH
Pharmatherapeutica; 1981; 3(1):46-54. PubMed ID: 7033992
[TBL] [Abstract][Full Text] [Related]
28. Acute hemodynamic effects of labetalol in severe hypertension.
Omvik P; Lund-Johansen P
J Cardiovasc Pharmacol; 1982; 4(6):915-20. PubMed ID: 6185782
[TBL] [Abstract][Full Text] [Related]
29. Treatment of severe hypertension by repeated bolus injections of labetalol.
Cumming AM; Brown JJ; Lever AF; Mackay A; Robertson JI
Br J Clin Pharmacol; 1979; 8(Suppl 2):199S-204S. PubMed ID: 393288
[No Abstract] [Full Text] [Related]
30. Labetalol in hypertension during the third trimester of pregnancy: its antihypertensive effect and pharmacokinetic-dynamic analysis.
Saotome T; Minoura S; Terashi K; Sato T; Echizen H; Ishizaki T
J Clin Pharmacol; 1993 Oct; 33(10):979-88. PubMed ID: 8227470
[TBL] [Abstract][Full Text] [Related]
31. Effects of intravenous labetalol on blood pressure, angiotensin II and aldosterone in hypertension: comparison with propranolol.
Rosei EA; Trust PM; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI
Clin Sci Mol Med Suppl; 1976 Dec; 3():497s-499s. PubMed ID: 1071671
[TBL] [Abstract][Full Text] [Related]
32. Acute effect of intravenous labetalol in the treatment of systemic arterial hypertension.
Ronne-Rasmussen JO; Andersen GS; Jensen NB; Andersson E
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):805-8. PubMed ID: 990157
[TBL] [Abstract][Full Text] [Related]
33. Comparison of labetalol versus enalapril as monotherapy in elderly patients with hypertension: results of 24-hour ambulatory blood pressure monitoring.
Applegate WB; Borhani N; DeQuattro V; Kaihlanen PM; Oishi S; Due DL; Sirgo MA
Am J Med; 1991 Feb; 90(2):198-205. PubMed ID: 1996588
[TBL] [Abstract][Full Text] [Related]
34. Comparison of labetalol and clonidine in hypertension.
Lilja M; Jounela AJ; Karppanen H
Eur J Clin Pharmacol; 1982; 21(5):363-7. PubMed ID: 7075640
[TBL] [Abstract][Full Text] [Related]
35. Labetalol for the control of elevated blood pressure following coronary artery bypass grafting.
Sladen RN; Klamerus KJ; Swafford MW; Prough DS; Mann HJ; Leslie JB; Goldberg JS; Levitsky S; Molina JE; Mills SA
J Cardiothorac Anesth; 1990 Apr; 4(2):210-21. PubMed ID: 2131869
[TBL] [Abstract][Full Text] [Related]
36. Dilevalol in severe hypertension. A multicenter trial of bolus intravenous dosing.
Wallin JD; Cook ME; Fletcher E; Holtzman JL; Winer N; Gavras H; Grim CE; Ramanathan KB; Vidt DG; Johnson BF
Arch Intern Med; 1989 Dec; 149(12):2655-61. PubMed ID: 2688585
[TBL] [Abstract][Full Text] [Related]
37. Hemodynamic effects of intravenous labetalol in essential hypertension.
Dunn FG; Oigman W; Messerli FH; Dreslinski GR; Reisin E; Frohlich ED
Clin Pharmacol Ther; 1983 Feb; 33(2):139-43. PubMed ID: 6822026
[TBL] [Abstract][Full Text] [Related]
38. [Effects of labetalol, a new alpha- and beta-adrenoreceptor blocking drug, on arterial pressure, renal function and renin activity (author's transl)].
Zech P; Pozet N; Sassard J; Vincent M
Nouv Presse Med; 1980 Mar; 9(15):1087-90. PubMed ID: 7008020
[TBL] [Abstract][Full Text] [Related]
39. Multicenter clinical evaluation of long-term efficacy and safety of labetalol in treatment of hypertension.
Michelson EL; Frishman WH; Lewis JE; Edwards WT; Flanigan WJ; Bloomfield SS; Johnson BF; Lucas C; Freis ED; Finnerty FA
Am J Med; 1983 Oct; 75(4A):68-80. PubMed ID: 6356901
[TBL] [Abstract][Full Text] [Related]
40. Labetalol in general practice: a review.
Kane JA
Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):59S-63S. PubMed ID: 7093101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
